Reports for BIVALIRUDIN
Ingredient
BIVALIRUDIN
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ANGIOMAX | 250MG | POWDER FOR SOLUTION | Resolved | 2022-12-12 | 2022-12-28 | 177911 |
| ANGIOMAX | 250MG | POWDER FOR SOLUTION | Actual shortage | 2026-03-09 | 2026-03-16 | 279966 |
| BIVALIRUDIN FOR INJECTION | 250MG | POWDER FOR SOLUTION | Resolved | 2021-11-24 | 2022-02-04 | 149848 |
| BIVALIRUDIN FOR INJECTION | 250MG | POWDER FOR SOLUTION | Resolved | 2022-10-02 | 2023-01-02 | 170875 |
| BIVALIRUDIN FOR INJECTION | 250MG | POWDER FOR SOLUTION | Resolved | 2023-08-03 | 2023-11-18 | 201032 |
| BIVALIRUDIN INJECTION | 5MG | SOLUTION | Resolved | 2022-10-11 | 2023-02-27 | 171467 |
| BIVALIRUDIN INJECTION | 5MG | SOLUTION | Resolved | 2025-04-02 | 2025-04-24 | 253968 |
| BIVALIRUDIN INJECTION | 5MG | SOLUTION | Actual shortage | 2025-12-16 | 2026-01-02 | 274457 |
Showing 1 to 8 of 8
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ANGIOMAX | 250MG | POWDER FOR SOLUTION | To be discontinued | 2026-03-16 | 2026-03-16 | 280590 |
Showing 1 to 1 of 1